Skip to main content
Clinical and Diagnostic Laboratory Immunology logoLink to Clinical and Diagnostic Laboratory Immunology
. 1995 Mar;2(2):238–240. doi: 10.1128/cdli.2.2.238-240.1995

Frequency of deviant immunological test values in chronic fatigue syndrome patients.

B H Natelson 1, S P Ellis 1, P J Braonáin 1, J DeLuca 1, W N Tapp 1
PMCID: PMC170136  PMID: 7697537

Abstract

Of 11 immunological tests done on chronic fatigue syndrome patients and on fatigued controls, 3 tests (protein A binding, Raji cell, or C3 or C4 [deviant values in either complement component were counted as positive]) with deviant results discriminated best among the groups. Other tests, including immunoglobulin G subclasses, complement component CH50, interleukin-2, and anticardiolipin antibodies, did not discriminate well among the groups.

Full Text

The Full Text of this article is available as a PDF (142.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barker E., Fujimura S. F., Fadem M. B., Landay A. L., Levy J. A. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis. 1994 Jan;18 (Suppl 1):S136–S141. doi: 10.1093/clinids/18.supplement_1.s136. [DOI] [PubMed] [Google Scholar]
  2. Bates D. W., Buchwald D., Lee J., Kith P., Doolittle T., Rutherford C., Churchill W. H., Schur P. H., Wener M., Wybenga D. Clinical laboratory test findings in patients with chronic fatigue syndrome. Arch Intern Med. 1995 Jan 9;155(1):97–103. [PubMed] [Google Scholar]
  3. Buchwald D., Komaroff A. L. Review of laboratory findings for patients with chronic fatigue syndrome. Rev Infect Dis. 1991 Jan-Feb;13 (Suppl 1):S12–S18. doi: 10.1093/clinids/13.supplement_1.s12. [DOI] [PubMed] [Google Scholar]
  4. Chao C. C., Gallagher M., Phair J., Peterson P. K. Serum neopterin and interleukin-6 levels in chronic fatigue syndrome. J Infect Dis. 1990 Dec;162(6):1412–1413. doi: 10.1093/infdis/162.6.1412-a. [DOI] [PubMed] [Google Scholar]
  5. Chao C. C., Janoff E. N., Hu S. X., Thomas K., Gallagher M., Tsang M., Peterson P. K. Altered cytokine release in peripheral blood mononuclear cell cultures from patients with the chronic fatigue syndrome. Cytokine. 1991 Jul;3(4):292–298. doi: 10.1016/1043-4666(91)90497-2. [DOI] [PubMed] [Google Scholar]
  6. Fukuda K., Straus S. E., Hickie I., Sharpe M. C., Dobbins J. G., Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994 Dec 15;121(12):953–959. doi: 10.7326/0003-4819-121-12-199412150-00009. [DOI] [PubMed] [Google Scholar]
  7. Holmes G. P., Kaplan J. E., Gantz N. M., Komaroff A. L., Schonberger L. B., Straus S. E., Jones J. F., Dubois R. E., Cunningham-Rundles C., Pahwa S. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988 Mar;108(3):387–389. doi: 10.7326/0003-4819-108-3-387. [DOI] [PubMed] [Google Scholar]
  8. Lloyd A. R., Wakefield D., Boughton C. R., Dwyer J. M. Immunological abnormalities in the chronic fatigue syndrome. Med J Aust. 1989 Aug 7;151(3):122–124. doi: 10.5694/j.1326-5377.1989.tb139594.x. [DOI] [PubMed] [Google Scholar]
  9. Robinson M. W., Scott D. G., Bacon P. A., Walton K. W., Coppock J. S., Scott D. L. What proteins are present in polyethylene glycol precipitates from rheumatic sera? Ann Rheum Dis. 1989 Jun;48(6):496–501. doi: 10.1136/ard.48.6.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Schluederberg A., Straus S. E., Peterson P., Blumenthal S., Komaroff A. L., Spring S. B., Landay A., Buchwald D. NIH conference. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann Intern Med. 1992 Aug 15;117(4):325–331. doi: 10.7326/0003-4819-117-4-325. [DOI] [PubMed] [Google Scholar]
  11. Wakefield D., Lloyd A., Brockman A. Immunoglobulin subclass abnormalities in patients with chronic fatigue syndrome. Pediatr Infect Dis J. 1990 Aug;9(8 Suppl):S50–S53. [PubMed] [Google Scholar]
  12. Wells K. B., Golding J. M., Burnam M. A. Chronic medical conditions in a sample of the general population with anxiety, affective, and substance use disorders. Am J Psychiatry. 1989 Nov;146(11):1440–1446. doi: 10.1176/ajp.146.11.1440. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Diagnostic Laboratory Immunology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES